Vivo Bio Tech (BOM:511509) Net Margin %: -36.35% (As of Mar. 2026)


BOM:511509 Vivo Bio Tech Ltd BOM:511509
68 GF Score
Price ₹23.04
GF Value ₹29.55
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech Net Margin %?

Vivo Bio Tech BOM:511509 -1.41% 68 Net Margin % is -36.35% as of Mar. 2026. GuruFocus rates BOM:511509 with a GF Score™ of 68/100 and a GF Value™ of ₹29.55 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 946 Biotechnology companies, Vivo Bio Tech ranks better than 69.56% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Vivo Bio Tech's Net Income for the three months ended in Mar. 2026 was ₹-51.6 Mil. Vivo Bio Tech's Revenue for the three months ended in Mar. 2026 was ₹142.0 Mil. Therefore, Vivo Bio Tech's net margin for the quarter that ended in Mar. 2026 was -36.35%.

The historical rank and industry rank for Vivo Bio Tech's Net Margin % or its related term are showing as below:

BOM:511509' s Net Margin % Range Over the Past 10 Years
Min: -3.2   Med: 6.1   Max: 15.6
Current: -3.2

BOM:511509's Net Margin % is ranked better than
69.56% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs BOM:511509: -3.20

Vivo Bio Tech  (BOM:511509) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Vivo Bio Tech Net Margin % Related Terms

Vivo Bio Tech Net Margin % Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech Net Margin % Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.28 5.07 5.56 15.60 -3.20

Vivo Bio Tech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.65 10.69 6.63 9.24 -36.35

BOM:511509 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Vivo Bio Tech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivo Bio Tech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's Net Margin % falls into.


BOM:511509
68GF Score
Vivo Bio Tech Ltd BOM:511509
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Vivo Bio Tech's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-17.088/533.347
=-3.20 %

Vivo Bio Tech's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-51.627/142.011
=-36.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -36.35% mean?
Vivo Bio Tech (BOM:511509) has a Net Margin % of -36.35% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Vivo Bio Tech and its competitors. According to the industry distribution chart, Vivo Bio Tech ranks #288 out of 946 companies in the Biotechnology industry, placing it in the top 30.4%.
Is Vivo Bio Tech's Net Margin % too high?
Vivo Bio Tech's current Net Margin % is -36.35%. Based on the distribution chart, Vivo Bio Tech ranks #288 out of 946 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Vivo Bio Tech has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vivo Bio Tech ranks #288 out of 946 companies for Net Margin %. This puts Vivo Bio Tech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Vivo Bio Tech and its competitors. Vivo Bio Tech's current Net Margin % is -36.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.55, compared to a current price of ₹23.04 — trading 22% below its estimated fair value. The current Net Margin % is -36.35%. Vivo Bio Tech's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Net Margin % is -36.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹23.04 is trading 22% below its estimated GF Value™ of ₹29.55. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • Net Margin %: -36.35%
  • GF Value™: ₹29.55 vs. price of ₹23.04 (22% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
68GF Score

Get the complete analysis for BOM:511509

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.04
Price
₹29.55
GF Value